Globus Medical Inc Class A GMED
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Kuehn Law Encourages Investors of Globus Medical, Inc. to Contact Law Firm
-
Globus Medical to Showcase SCRIPT™ Patient-Specific Implants and New XLIF™ Prone Procedural Solution at NASS 2026
-
Globus Medical Schedules Third Quarter Earnings Release and Conference Call
-
Globus Medical Announces CE Mark for Excelsius3D™ Imaging System
-
Globus Medical Announces Acquisition of Higgs Boson Health to Transform Healthcare Experience Through AI-Driven Digital Solutions
-
Globus Medical Reports Second Quarter 2026 Results
-
Kuehn Law Encourages Investors of Globus Medical, Inc. to Contact Law Firm
Trading Information
- Previous Close Price
- $78.96
- Day Range
- $77.96–79.95
- 52-Week Range
- $59.51–101.40
- Bid/Ask
- $73.50 / $80.00
- Shares Outstanding
- 134.26M
- Market Cap
- $10.56B
- Volume/Avg
- 1M / 1M
Key Statistics
- Price/Earnings (Normalized)
- 16.00
- Price/Sales
- 3.42
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- 2.09%
Company Profile
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- 6,000
- Website
- https://www.globusmedical.com
Valuation
|
Metric
|
GMED
|
|---|---|
Price/Earnings (Normalized) | 16.00 |
Price/Book Value | 2.22 |
Price/Sales | 3.42 |
Price/Cash Flow | 10.63 |
Price/Earnings
GMED
Financial Strength
|
Metric
|
GMED
|
|---|---|
Quick Ratio | 2.78 |
Current Ratio | 4.62 |
Interest Coverage | — |
Quick Ratio
GMED
Profitability
|
Metric
|
GMED
|
|---|---|
Return on Assets (Normalized) | 12.80% |
Return on Equity (Normalized) | 14.78% |
Return on Invested Capital (Normalized) | 14.11% |
Return on Assets
GMED
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|@y&v>^< | LOCK|jPHM | $174B | |||
| Medtronic PLC
MDT
| LOCK|bqF@GJ? | LOCK|>??Q! | $119B | |||
| Stryker Corp
SYK
| LOCK|<L?l!zpb | LOCK|w@$ | $114B | |||
| Boston Scientific Corp
BSX
| LOCK|Ljn?<Z | LOCK|Zf#P | $65B | |||
| Edwards Lifesciences Corp
EW
| LOCK|Y@@CG&J& | LOCK|l%$y$ | $51B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|<$VMH< | LOCK|t<^ | $31B | |||
| DexCom Inc
DXCM
| LOCK|^%Zz$p^ | LOCK|@Jj> | $30B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|@&g | LOCK|?l | $26B | |||
| Steris PLC
STE
| LOCK|Gr$w$< | LOCK|x<Yy | $22B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|cs#LLpV | LOCK|fmM | $18B |
United States